GMED ▼ -3.1% - Globus Medical, Inc. $GMED - Globus Medical Announces CE Mark for Excelsius3D™ Imaging System Globus Medical shares fell 3.1% despite the company announcing CE Mark approval for its Excelsius3D™ Imaging System, which clears the way for the device to be marketed in European Union countries. The decline suggests investors may have been pricing in the regulatory milestone ahead of the announcement, or the market viewed the news as already reflected in the stock's valuation. 03-SEP-2026 04:30 PM ET